Effect of Two Lipoprotein (a)-Associated Genetic Variants on Plasminogen Levels and Fibrinolysis
Two genetic variants (rs3798220 and rs10455872) in the apolipoprotein (a) gene (LPA) have been implicated in cardiovascular disease (CVD), presumably through their association with lipoprotein (a) [Lp(a)] levels. While Lp(a) is recognized as a lipoprotein with atherogenic and thrombogenic characteri...
Main Authors: | Hong Wang, Chan E. Hong, Joshua P. Lewis, Yanbei Zhu, Xing Wang, Xin Chu, Joshua Backman, Ziying Hu, Peixin Yang, Christopher D. Still, Glenn S. Gerhard, Mao Fu |
---|---|
Format: | Article |
Language: | English |
Published: |
Oxford University Press
2016-11-01
|
Series: | G3: Genes, Genomes, Genetics |
Subjects: | |
Online Access: | http://g3journal.org/lookup/doi/10.1534/g3.116.034702 |
Similar Items
-
Plasminogen Receptors and Fibrinolysis
by: Lindsey A. Miles, et al.
Published: (2021-02-01) -
HDL3, but not HDL2, stimulates plasminogen activator inhibitor-1 release from adipocytes: the role of sphingosine-1-phosphate
by: Mi-Hye Lee, et al.
Published: (2010-09-01) -
Fibrinolysis and bleeding of unknown cause
by: Dino Mehic, et al.
Published: (2021-05-01) -
“Going with the flow” in modeling fibrinolysis
by: Claire S. Whyte, et al.
Published: (2022-12-01) -
Modulation of staphylokinase-dependent plasminogen activation by mono- and divalent ions
by: Yarzábal A., et al.
Published: (1999-01-01)